Skip to main content
SpringerLink
Log in

Imaging of the Male Pelvis

  • Chapter
Diseases of The Abdomen and Pelvis

  • 907 Accesses

Abstract

Prostate cancer continues to be the leading cancer among American men, with 184,500 new cases annually [1]. It has been estimated that 39,200 men died of prostate cancer in the U.S.A. in 1998. This makes prostate cancer the second cause of cancer-related death in men [2, 3]. Furthermore, the probability of developing prostate cancer from birth to death is 20% [3]. Treatment selection is dependent on patient age and health, cancer stage and grade, morbidity and mortality of treatment, as well as patient and physician preference. The mainstay for organ-confined disease is either radical surgery or curative radiotherapy [4, 5]. This is only considered an option in the absence of seminal vesicle infiltration (SVI), extension through the prostatic capsule (extracapsular extension, ECE) or metastatic disease. Therefore, the purpose of staging is the possible detection of extraprostatic disease. Clinical staging by digital rectal examination (DRE) and prostate specific antigen (PSA) remains as yet inaccurate. Imaging modalities such as transrectal ultrasound (TRUS) and magnetic resonance (MR) imaging can be used to increase staging accuracy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics. CA Cancer J Clin 48:6–29

    PubMed  CAS  Google Scholar 

  2. Imperial Cancer Research Fund (1995) Cancer statistics (online: http:www.icnetuk/research/factsheet/canstats.html)

    Google Scholar 

  3. American Cancer Society (1998) Cancer facts and figures. http://www.cancer.org.statisticscff98/graphicaldata.html

    Google Scholar 

  4. Catalona WJ (1995) Surgical management of prostate cancer: contemporary results with anatomic radical prostatectomy. Cancer 75:1903–1908

    Article  Google Scholar 

  5. Donovan JL, Frankel SJ, Faulkner A et al (1999) Dilemmas in treating early prostate cancer: the evidence and a questionaire survey of consultant urologists in the United Kingdom. BMJ 318:299–300

    PubMed  CAS  Google Scholar 

  6. Jewett HJ (1956) Significance of the palpable prostatic nodule. JAMA 160:838–939

    CAS  Google Scholar 

  7. Smith DS, Catalona WJ (1995) Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45:70–74

    Article  PubMed  CAS  Google Scholar 

  8. Voges GE, McNeal JE, Redwine E et al (1992) Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 69:520–526

    Article  PubMed  CAS  Google Scholar 

  9. Epstein JI, Pizov G, Walsh PC (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71:3582–3593

    Article  PubMed  CAS  Google Scholar 

  10. Partin AW, Yoo J, Ballentine Carter JY et al (1993) The use of prostate specific antigen, clinical stage and gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110–115

    PubMed  CAS  Google Scholar 

  11. Kleer E, Oesterling JE (1993) PSA and staging of localized prostate cancer. Urol Clin North Am 20:695–704

    PubMed  CAS  Google Scholar 

  12. Jager GJ, Barentsz JO (1998) Prostate cancer. In: Husband J (ed) Oncology imaging. Isis Medical Media, Oxford, pp 239–257

    Google Scholar 

  13. Langlotz CP (1996) Benefits and costs of MR imaging of prostate cancer. MR Clin Nort Am 4:533–545

    CAS  Google Scholar 

  14. Schiebler ML, Schnall MD, Pollack HM et al (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339–352

    PubMed  CAS  Google Scholar 

  15. Chernoff DM, Hricak H, Higgins CB, Hricak H (1997) The Male pelvis: prostate and seminal vesicles. In: Hricak H (ed) Magnetic resonance imaging of the body, 3rd edn. Lippincott-Raven Press, New York, pp 875–900

    Google Scholar 

  16. Ramchandani P, Schnall MD, LiVolsi VA et al (1993) Senile amyloidosis of the seminal vesicles mimicking metastatic spread of prostatic carcinoma on MR images. AJR Am J Roentgenol 161:99–100

    PubMed  CAS  Google Scholar 

  17. Jager G, Ruijter E, de la Rosette J, van de Kaa CA (1997) Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images. Eur J Radiol 7:552–554

    Article  CAS  Google Scholar 

  18. Langlotz CP, Schnall MD, Pollack H (1995) Staging of prostatic cancer: accuracy of MR imaging. Radiology 194:645–646

    PubMed  CAS  Google Scholar 

  19. Jager GJ, Thornbury J, Barentsz JO et al (1998) MR staging in prostate cancer (pc): influence on patient outcome and effective analysis. Abstract, RSNA 181

    Google Scholar 

  20. Rifkin MD, Zerhouni EA, Gatsonis CA et al (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 323:621–626

    Article  PubMed  CAS  Google Scholar 

  21. Rørvik J, Halvorsen OJ, Albrektsen G et al (1999) MR imaging with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 9:29–34

    Article  PubMed  Google Scholar 

  22. Schnall MD, Imai Y, Tomaszewski JE et al (1991) Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 178:797–802

    PubMed  CAS  Google Scholar 

  23. Hricak H, White S, Vigneron DB et al (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703–709

    PubMed  CAS  Google Scholar 

  24. Bartolozzi C, Menchi I, Lencioni R et al (1996) Local staging of prostate carcinoma with endorectal coil MR imaging: correlation with whole mount radical prostatectomy specimens. Eur Radiol 6:339–345

    PubMed  CAS  Google Scholar 

  25. Langlotz CP, Schnall MD, Malkowicz SB, Schwartz JS (1996) Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Acad Radiol 3:24–27

    Article  Google Scholar 

  26. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391–395

    PubMed  CAS  Google Scholar 

  27. Outwater E, Petersen RO, Siegelman ES et al (1994) Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333–339

    PubMed  CAS  Google Scholar 

  28. White S, Hricak H, Forstner R et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390

    PubMed  CAS  Google Scholar 

  29. Kedar RP, Kier R, Viner N (1999) Proceedings of the International Society of Magnetic Resonance in Medicine (poster ISMRM, Philadelphia) nr. 1106

    Google Scholar 

  30. Scheidler J, Hricak H, Yu KK et al (1997) Radiological Evaluation of lymph node metastases in patients with cervical cancer. JAMA 278:1096–1101

    Article  PubMed  CAS  Google Scholar 

  31. Jager GJ, Barentsz JO, Oosterhof G, Ruijs JHJ (1996) 3D dimensional MR imaging in nodal staging of bladder and prostate cancer. AJR Am J Roentgenol 1503–1507

    Google Scholar 

  32. Barentsz JO (1997) MR-intervention in the pelvis: an overview and first experiences in MR-guided biopsy in nodal metastases in urinary bladder cancer. Abdominal Radiology 22:524–530

    Article  CAS  Google Scholar 

  33. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE (1995) Normal pelvic lymph nodes: evaluation by CT scanning after bipedal lymphangiography. Radiology 194:349–355

    PubMed  CAS  Google Scholar 

  34. Oyen RH, Van Poppel HP, Ameye FE et al (1994) Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 190:315–322

    PubMed  CAS  Google Scholar 

  35. Wolf JS, Cher M, Dall’era M et al (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153:993–999

    Article  PubMed  Google Scholar 

  36. Haukaas S, Rørvik J, Halvorsen OJ, Foellings M (1997) When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer. Br J Urol 79:770–776

    PubMed  CAS  Google Scholar 

  37. Algra PR, Bloem JL, Tissing H et al (1991) Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 11:219–323

    PubMed  CAS  Google Scholar 

  38. Delorme S, Knopp MV (1998) Non-invasive vascular imaging: assessing tumour vascularity Eur J Radiol 4:517–527

    Google Scholar 

  39. Jager G, Ruijter E, Kaa van de C et al (1997) Dynamic turbo-flash subtraction technique for contrast-enhanced MR images of the prostate: correlation with histopathology. Radiology 203:645–652

    PubMed  CAS  Google Scholar 

  40. Futterer JJ, Engelbrecht MR, Huisman HJ et al (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–547

    Article  PubMed  Google Scholar 

  41. Padhani AR, MacVicar AD, Gapinski CJ et al (2001) Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218:365–374

    PubMed  CAS  Google Scholar 

  42. Engelbrecht MR, Huisman HJ, Laheij RJ et al (2003), Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229:248–254

    Article  PubMed  Google Scholar 

  43. Kurhanewicz J, Males R, Sokolov D (1998) Combined endorectal/phased-array MR imaging and 3-D H-MR Spectroscopic imaging for improved diagnosis of extracapsular extension in prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia)

    Google Scholar 

  44. Heerschap A, Jager GJ, van der Graaf M et al (1997) In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 17:1455–1460

    PubMed  CAS  Google Scholar 

  45. Kurhanewicz J, Vigneron DB, Hricak H et al (1998) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.77-cm3) spatial resolution. Radiology 198:795–805

    Google Scholar 

  46. Vigneron DB, Males R, Noworolski S (1998) 3D MRSI of prostate cancer: correlations with histologic grade. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia)

    Google Scholar 

  47. Males R, Vigneron DB, Nelson AD (1998) Addition of MR spectroscopic imaging to MRI significantly improves detection and localization of prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia)

    Google Scholar 

  48. Weissleder R, Elizondo G, Wittenberg J et al (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymphnodes with MR imaging. Radiology 175:494–498

    PubMed  CAS  Google Scholar 

  49. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499

    Article  PubMed  Google Scholar 

  50. Futterer JJ, Scheenen TW, Huisman HJ et al (2004) Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39:671–680

    Article  PubMed  Google Scholar 

  51. Fütterer J, Heijmink S, Scheenen T et al (2006) Local staging of prostate cancer using 3T endorectal coil MR imaging — Early Experience. Radiology 238:184–191

    Article  PubMed  Google Scholar 

  52. Presti JC, Hricak H, Narayan P et al (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol 166:103–108

    PubMed  Google Scholar 

  53. Yu KK, Hricak H, Alagappan R et al (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202:697–702

    PubMed  CAS  Google Scholar 

  54. Jager GJ, Severens JL, Thornbury JR et al (2000) Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 215:445–451

    PubMed  CAS  Google Scholar 

  55. Barentsz JO, Debruyne FMJ, Ruijs SHJ (eds) (1990) Magnetic resonance imaging of carcinoma of the urinary bladder. Kluwer Academic Publishers, Dordracht, London, Boston

    Google Scholar 

  56. Barentsz JO, Jager GJ, van Vierzen PB et al (1996) Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201:185–193

    PubMed  CAS  Google Scholar 

  57. Barentsz JO, Jager GJ, Mugler JP et al (1995) Staging urinary bladder cancer, value of T1weighted three-dimensional magnetization prepared-rapid gradient-echo two-dimensional spin-echo sequences. AJR Am J Roentgenal 164:109–115

    CAS  Google Scholar 

  58. Jager GJ, Barentsz JO, Oosterhof GO et al (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol. 167:1503–1507

    PubMed  CAS  Google Scholar 

  59. Barentsz JO, Berger-Hartog O, Witjes JA et al (1998) Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207:791–7

    PubMed  CAS  Google Scholar 

  60. Maeda H, Kinukawa T, Hottori R et al (1995) Detection of muscle layer invasion with submillmeter pixel MRI: Staging of bladder carcinoma. Magn Reson Imaging 13:9–19

    Article  PubMed  CAS  Google Scholar 

  61. Hricak H, White S (1997) Radiological evaluation of the urinary bladder and prostate. In: Grainger RG, Allison D (eds) Grainger and Allison’s diagnostic radiology: a textbook of medical imaging, Vol. 2, 3rd edn. Churchill Livingstone, New York, pp 1427–1438

    Google Scholar 

  62. Sherwood T (1980) Bladder and urethra. In: Sherwood T, Davidson AJ, Talner LB (eds) Uro-Radiology, 1st edn, Part 4, Division 3. Blackwell Scientific, Oxford, pp 255–312

    Google Scholar 

  63. Hatch TR, Barry JM (1986) The value of excretory urography in staging bladder cancer. J Urol 135:49–54

    PubMed  CAS  Google Scholar 

  64. Richards D, Jones S (1998) The bladder and prostate. In: Sutton D (ed) Textbook of radiology and imaging. 6th British Library cataloguing in publication data. Longman Asia, Hong Kong, pp 1167–1187

    Google Scholar 

  65. Dershow PD, Scher HI (1987) Sonography in the evaluation of carcinoma of the bladder urology 29:454–457

    Google Scholar 

  66. Barentsz JO, Jager GJ, Witjes JA, Ruijs JHJ (1996) Primary staging of urinary bladder carcinoma: the role of MR imaging and a comparison with CT. Eur Radiol 6:134–139

    Article  Google Scholar 

  67. Barentsz JO, Witjes JA, Ruijs JH (1997) What is new in bladder cancer imaging. Urol Clin North Am 24:583–602

    Article  PubMed  CAS  Google Scholar 

  68. Takeda K, Kawaguchi T, Shiraishi T et al (1998) Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endo-rectal surface coil and histological assessment of submucosal linear enhancement using, Gd-DTPA auto-radiography in an animal model. Eur J Radiol 26:290–296

    Article  PubMed  CAS  Google Scholar 

  69. Barentsz JO (1998) Magnetic resonance imaging of urinary bladder carcinoma. In: Jafri SH, Diokno AC, Amendola MA (eds) Lower genitourinary radiology, imaging and intervention. Springer-Verlag, New York, pp 138–158

    Google Scholar 

  70. Barentsz JO, Ruijs JHJ, Strijk SP (1993) The role of MR imaging in carcinoma of the urinary bladder. AJR Am J Roentgenol 160:937–947

    PubMed  CAS  Google Scholar 

  71. Siegelman ES, Schnall MD (1996) Contrast-enhanced MR imaging of the bladder and prostate. Magn Reson Imaging Clin N Am 4:153–169

    PubMed  CAS  Google Scholar 

  72. Narumi Y, Kadota T, Inoue E et al (1993) Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. Radiology 187:145–50

    PubMed  CAS  Google Scholar 

  73. Eustace S, Tello R, De Carvalho V et al (1997) A comparison of whole body turbo short tau inversion recovery MR imaging and planar technetium 99m methylene diphosphonate scintigraphy in the evaluation of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1655–1661

    PubMed  CAS  Google Scholar 

  74. Padhani AR, Husband JE (2001) Dynamic contrast enhanced MRI studies in oncology with an emphasis on quantification, validation human studies. Clin Radiol 56:607–620

    Article  PubMed  CAS  Google Scholar 

  75. Lin W, Hoacke EM, Smith AS et al (1992) Gadolinium enhanced high resolution MRA with adaptive vessel tracking: preliminary results in the intracranial circulation. Magn Reson Imaging 2:227–284

    Google Scholar 

  76. Vens S, Hosten N, Ilg J et al (1996) Pre-operative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTTA-supported spin-echo sequences. Rofo 164:218–225

    Google Scholar 

  77. Hamm P, Laniado M, Saini S (1990) Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis. Magn Reson 6:108–135

    CAS  Google Scholar 

  78. El-Diasty T, EI-Sobky E, Abou EI-Ghar M et al (2002) Triphasic helical CT of urinary bladder carcinomas correlation with tumour angiogenesis and pathologic types. Eur Radol 12:D1–D25 (abs)

    Article  Google Scholar 

  79. Nicolas V, Spielmann R, Mass R et al (1991) The diagnostic value of MRI tomography following gadolinium-DTPA compared to computed-tomography in bladder tumors [German]. Rofo 154:357–363

    Google Scholar 

  80. Braun RD, Lanzen JL, Dewhirst NW (1999) Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle of rats. Am J Physiol 277:551–568

    Google Scholar 

  81. Dovark HF, Nagy JA, Feng D et al (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of micro-vascular hyper-permeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132

    Google Scholar 

  82. Dewhirst M (1993) Angiogenesis and blood flow in solid tumors. In: Teicher B (ed) Drug resistance in oncology. New York, NY, USA, pp 3–24

    Google Scholar 

  83. Neeman M, Provenzale JP, Dewhirst MW (2001) MRI application in evaluation of tumor angiogenesis. Semin Radiol Oncol 11:70–82

    Article  CAS  Google Scholar 

  84. Saito W, Amanuma M, Tanaka J et al (2000) Histopathological analysis of bladder cancer stalk observed on MRI. Magn Reson Imaging 18:411 (abs)

    Article  PubMed  CAS  Google Scholar 

  85. Husband JE (1992) Review of staging bladder cancer. Clin Radiol 46:153–159

    Article  PubMed  CAS  Google Scholar 

  86. Wolf JS, Cher M, Dall’era M et al (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153:993–999

    Article  PubMed  Google Scholar 

  87. Vassallo P, Matei C, Heston WDW et al (1994) AMI-227-enhanced MR Lymphography: usefulness for differentiating reactive from tumor bearing lymph nodes. Radiology 193:501–506

    PubMed  CAS  Google Scholar 

  88. Weissleder R, Elizondo G, Wittenberg J et al (1990) Ultrasmall paramagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494–498

    PubMed  CAS  Google Scholar 

  89. Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31:288–305

    Article  PubMed  CAS  Google Scholar 

  90. Bellin MF, Roy C, Kinkel K et al (1998) Lymph node metastases: safety and effectiveness of MRI with ultrasmall superparamanetic iron oxide particles-initial clinical experience. Radiology 207:799–808

    PubMed  CAS  Google Scholar 

  91. Harisinghani MG, Saini S, Slater GJ et al (1997) MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 7:161–163

    Article  PubMed  CAS  Google Scholar 

  92. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499

    Article  PubMed  Google Scholar 

  93. Deserno WM, Harisinghani MG, Taupitz M et al (2004) Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233:449–456

    Article  PubMed  Google Scholar 

  94. Woodward PJ, Sohaey R, O’Donoghue MJ, Green DE (2002) Tumors and tumorlike lesions of the testis: radiologic-pathologic correlation. Radiographics 22:189–216

    PubMed  Google Scholar 

  95. Maizlin ZV, Belenky A, Kunichezky M et al (2004) Leydig cell tumors of the testis: gray scale and color Doppler sonographic appearance. J Ultrasound Med 23:959–964

    PubMed  Google Scholar 

  96. Mazzu D, Jeffrey RB, Ralls PW (1995) Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography. AJR Am J Roentgen 164:645–647

    CAS  Google Scholar 

  97. Tartar VM, Trambert MA, Balsara ZN, Mattrey RF (1993) Tubular ectasia of the testicle: sonographic and MR imaging appearance. AJR Am J Roentgenol 160:539–542

    PubMed  CAS  Google Scholar 

  98. Cho J-H, Chang J-C, Park B-H et al (2002) Sonographic and MR imaging findings of testicular epidermoid cysts. AMJ Am J Roentgenol 178:743–748

    Google Scholar 

  99. Maizlin ZV, Belenky A, Baniel J et al (2005) Epidermoid cyst and teratoma of the testis: sonographic and histologic similarities. J Ultrasound Med 24:1403–1409

    PubMed  Google Scholar 

  100. Nagamine WH, Mehta SV, Vade A (2005) Testicular adrenal rest tumors in a patient with congenital adrenal hyperplasia: sonographic and magnetic resonance imaging findings. J Ultrasound Med 24:1717–1720

    PubMed  Google Scholar 

  101. Peterson AC, Bauman JM, Light DE et al (2001) The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old. J Urol 166:2061–2064

    Article  PubMed  CAS  Google Scholar 

  102. Bach AM, Hann LE, Shi W et al (2003) Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis? AJR Am J Roentgen 180:497–500

    Google Scholar 

  103. Cast JEI, Nelson WM, Early AS et al (2000) Testicular microlithiasis: prevalence and tumor risk in a population referred for scrotal sonography. AJR Am J Roentgen 175:1703–1706

    CAS  Google Scholar 

  104. Dogra VS, Rubens DJ, Gottlieb RH, Bhatt S (2004) Torsion and beyond: new twists in spectral Doppler evaluation of the scrotum. J Ultrasound Med 23:1077–1085

    PubMed  Google Scholar 

  105. Middleton WD, Middleton MA, Dierks M et al (1997) Sonographic prediction of viability in testicular torsion: preliminary observations. J Ultrasound Med 16:23–27

    PubMed  CAS  Google Scholar 

  106. Fernández-Pérez GC, Tardáguila FM, Velasco M et al (2005) Radiologic findings of segmental testicular infarction. AJR Am J Roentgenol 184:1587–1593

    PubMed  Google Scholar 

  107. Woodward PJ, Schwab CM, Sesterhenn IA (2003) Extratesticular scrotal masses: radiologic-pathologic correlation. Radiographics 23:215–240

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Medical Center St Radboud, Nijmegen, The Netherlands

    J. O. Barentsz

  2. Department of Radiology, The Reading Hospital and Medical Center, West Reading, PA

    B. J. Wagner

  3. Department of Radiology, Urology and Nephrology Center, Mansoura, Egypt

    E. Abouh-Bieh

  4. Armed Forces Institute of Pathology, Washington, DC, USA

    B. J. Wagner

Authors
  1. J. O. Barentsz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Abouh-Bieh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, University Hospital Balgrist, Zurich, Switzerland

    J. Hodler

  2. Nuklearmedizin, Universitätsspital, Zurich, Switzerland

    G. K. Von Schulthess

  3. Kantonsspital, Institut für Radiologie, Winterthur, Switzerland

    Ch. L. Zollikofer

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Barentsz, J.O., Wagner, B.J., Abouh-Bieh, E. (2006). Imaging of the Male Pelvis. In: Hodler, J., Von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of The Abdomen and Pelvis. Springer, Milano. https://doi.org/10.1007/88-470-0508-6_23

Download citation

  • DOI: https://doi.org/10.1007/88-470-0508-6_23

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0470-2

  • Online ISBN: 978-88-470-0508-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation